Navigation Links
SafeCode Drug Technologies Corp. in Negotiations With Manufacturers to Develop Prototype
Date:11/8/2012

JERUSALEM, November 8, 2012 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, the company is in negotiations with several manufacturers for the development of the company's first product prototype.

A video demonstration of the product applications can be viewed at http://youtube/PEy9ygT6jaA.

SafeCode is the developer of the world's first patent-protected voice recognition technology used to confirm prescription medications prior to their administration at home or in a medical center.  

Using SafeCode technology, prescription medications stored in specially designed locked containers can only be accessed and administered once the caregiver or patient correctly announces the name of the drug.

The technology ensures that the appropriate medication is being administered, as mistakes have accounted for thousands of deaths in recent years.  Often, nurses, doctors or patients are not careful when giving or taking medications and much medication's packaging may look similar. SafeCode Technology prevents medication errors, and thereby reduces the risk of severe injury or accidental death.

"We are hopeful that a contract with a manufacturer will be signed in the coming weeks, enabling us to build our first product prototype," said Joel Klopfer, Chief Executive Officer of SafeCode Drug Technologies.  "There is a large addressable market for this technology due to the thousands of deaths each year related to medication errors."

About SafeCode Drug Technologies

SafeCode Drug Technologies is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.  

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact:
Joel Klopfer
Joel.Klofer1@gmail.com
+9722-5021322


'/>"/>
SOURCE Safecode Drug Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
2. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
3. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
4. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
5. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
6. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
7. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
8. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
9. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
10. MedClean Technologies Announces 2011 Results
11. Patient Safety Technologies Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Feb. 23, 2017 Nevro Corp. (NYSE: NVRO), a ... for the treatment of chronic pain, today reported financial results ... 2016. 2016 Accomplishment & Highlights: ... 2016, an increase of 228% as reported, over the prior ... an increase of 612% over the prior year ...
(Date:2/23/2017)... 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price Analysis ... the global Fibromyalgia market. The research answers the following ... for Fibromyalgia and their clinical attributes? How are they positioned in ...
(Date:2/23/2017)... PUNE, India , February 23, 2017 ... "Diagnostic Imaging Market by Product (X-ray Imaging Digital, Analog), ... PET)), Application (OB/GYN, MSK, Cardiology, Oncology), End User (Hospitals, ... MarketsandMarkets, the report studies the global market over the ... expected to reach ~USD 36.43 Billion by 2021, at ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... The California State ... convening academic faculty engaged in or interested in palliative care education and research. The ... be held in North County San Diego on Sept. 28 and 29, 2017, on ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The International ... 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected ... will be showcased and the winner revealed at the 31st annual iaedp Symposium, March ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The ... for excellence in radiology marketing programs at the annual Building Better Radiology Marketing ... Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given out in ...
(Date:2/24/2017)... CA (PRWEB) , ... February 24, 2017 , ... ... for qualifying into the Senior International Elite division on February 12th. Ms. ... Around divisions at the elite qualifier competition held in Las Vegas, Nevada. Frida ...
(Date:2/23/2017)... ... 2017 , ... Thinksport, the most award-winning sunscreen on the ... Marin. For the second year in a row, cyclists will stay protected from ... thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts again ...
Breaking Medicine News(10 mins):